VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 140 filers reported holding VERASTEM INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $37,000 | +208.3% | 43,152 | +343.5% | 0.00% | – |
| Q2 2022 | $12,000 | -14.3% | 9,729 | -4.3% | 0.00% | – |
| Q1 2022 | $14,000 | -98.5% | 10,171 | -97.8% | 0.00% | -100.0% |
| Q4 2021 | $956,000 | +4.7% | 466,502 | +57.4% | 0.00% | 0.0% |
| Q3 2021 | $913,000 | -40.7% | 296,342 | -21.6% | 0.00% | 0.0% |
| Q2 2021 | $1,539,000 | +4175.0% | 378,097 | +2501.8% | 0.00% | – |
| Q1 2021 | $36,000 | -55.6% | 14,532 | -61.7% | 0.00% | – |
| Q4 2020 | $81,000 | +636.4% | 37,965 | +304.5% | 0.00% | – |
| Q3 2020 | $11,000 | -86.1% | 9,385 | -79.6% | 0.00% | – |
| Q2 2020 | $79,000 | +229.2% | 45,929 | +406.2% | 0.00% | – |
| Q1 2020 | $24,000 | +100.0% | 9,073 | -0.9% | 0.00% | – |
| Q4 2019 | $12,000 | -93.1% | 9,155 | -93.7% | 0.00% | – |
| Q3 2019 | $175,000 | -21.2% | 144,500 | -1.8% | 0.00% | – |
| Q2 2019 | $222,000 | +1750.0% | 147,102 | +3552.0% | 0.00% | – |
| Q1 2019 | $12,000 | -99.6% | 4,028 | -99.6% | 0.00% | -100.0% |
| Q4 2018 | $3,054,000 | +60.6% | 908,904 | +246.4% | 0.00% | +50.0% |
| Q3 2018 | $1,902,000 | +3704.0% | 262,359 | +3524.7% | 0.00% | – |
| Q2 2018 | $50,000 | +19.0% | 7,238 | -73.2% | 0.00% | – |
| Q1 2016 | $42,000 | +110.0% | 27,054 | +150.8% | 0.00% | – |
| Q4 2015 | $20,000 | +100.0% | 10,785 | +85.5% | 0.00% | – |
| Q3 2015 | $10,000 | -71.4% | 5,814 | +23.4% | 0.00% | – |
| Q2 2015 | $35,000 | -43.5% | 4,711 | -22.2% | 0.00% | – |
| Q1 2015 | $62,000 | -27.1% | 6,054 | -35.2% | 0.00% | – |
| Q4 2014 | $85,000 | +608.3% | 9,337 | +574.6% | 0.00% | – |
| Q3 2014 | $12,000 | +500.0% | 1,384 | +632.3% | 0.00% | – |
| Q2 2014 | $2,000 | -96.0% | 189 | -95.9% | 0.00% | – |
| Q1 2014 | $50,000 | -39.8% | 4,588 | -37.4% | 0.00% | – |
| Q4 2013 | $83,000 | +4050.0% | 7,327 | +3261.0% | 0.00% | – |
| Q3 2013 | $2,000 | – | 218 | +808.3% | 0.00% | – |
| Q2 2013 | $0 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |